Magellan Health, Inc. MGLN
$ 94.44
-0.19%
Country |
USA |
IPO year |
- |
Industry |
Health care |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Mr. Kenneth Fasola |
Employees in the company |
10 100 |
Shares |
25.8 M |
Market Cap[1] |
$ 2.49 B |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Health care"
Issuer | Price | % 24h | Market Cap | Exchange | Country | |
---|---|---|---|---|---|---|
Anthem
ANTM
|
$ 444.32 | -2.32 % | $ 107 B | NYSE,SPB | USA | |
Triple-S Management Corporation
GTS
|
$ 35.58 | 0.28 % | $ 847 M | NYSE | USA | |
Centene Corporation
CNC
|
$ 60.03 | 0.54 % | $ 32.6 B | NYSE,SPB | USA | |
UnitedHealth Group Inc.
UNH
|
$ 502.18 | 2.64 % | $ 466 B | NYSE,SPB | USA | |
Cigna Corporation
CI
|
$ 277.54 | 1.0 % | $ 81.2 B | NYSE,SPB | USA | |
Humana
HUM
|
$ 247.5 | 4.97 % | $ 30.7 B | NYSE,SPB | USA | |
NovoCure Limited
NVCR
|
$ 30.65 | 0.82 % | $ 3.26 B | Nasdaq Global Select Market,SPB | Jersey | |
CVS Health Corporation
CVS
|
$ 44.36 | 1.32 % | $ 57 B | NYSE,SPB | USA | |
Molina Healthcare
MOH
|
$ 295.9 | 0.81 % | $ 17.1 B | NYSE,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.